🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT07443670
Recruiting Observational

Voice Analysis to Detect Pulmonary Arterial Pressure Changes in Heart Failure

NCT07443670 · tracked via the Priya Life Science USA tracker
Sponsor
Noah Labs
Phase
Observational
Started
2024-12-12
Last updated
2026-03-02

Condition(s) studied

Heart Failure

Investigational drug(s) / intervention(s)

Daily Voice Recording

Daily Voice Recording: Patients record daily voice samples (sustained vowels and a standardized reading passage) using the Noah Labs mobile app. PA pressure readings are collected daily per standard care using the implanted sensor. Voice recordings are analyzed retrospectively using machine learning algorithms after study completion.

Study summary

VAPP-HF is a prospective, multi-center, observational study assessing whether daily voice recordings analyzed by a machine learning algorithm can detect changes in pulmonary arterial (PA) pressure in heart failure patients with implanted PA pressure sensors (e.g., CardioMEMS, Cordella). Patients across three sites in Germany and the United States provide daily voice recordings via a mobile app for 12 weeks while continuing standard PA pressure monitoring and heart failure care. Voice data is analyzed retrospectively after study completion; no clinical decisions are based on voice analysis during the study. The primary endpoint is the sensitivity and specificity of the AI-based voice analysis in detecting PA pressure changes at defined thresholds.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Age 18 years or older * Successful implantation of a PA pressure sensor and monitored by a participating study center * Willingness to record a short predefined text daily for 3 months using a smartphone or tablet * Ability to comfortably read aloud the study passage in English or German * Written informed consent obtained Exclusion Criteria: * Pregnant, breastfeeding, or unwilling to practice birth control during participation * Condition that in the opinion of the investigator would compromise patient safety or data quality * Pathological voice changes due to surgery or injury * Planned invasive cardiac procedures during the study period * COPD requiring home oxygen therapy * Chronic kidney disease requiring dialysis * Cognitive dysfunction limiting ability to perform daily voice recording * Inability to read English or German * Physical inability to use the recording device

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
University of California, San Francisco (UCSF) San Francisco California Recruiting
BG Klinikum Unfallkrankenhaus Berlin, Dept. of Cardiology Berlin State of Berlin Completed
University Hospital Frankfurt, Dept. of Cardiology and Angiology Frankfurt Germany Completed

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07443670 on ClinicalTrials.gov ↗ ← All trials in the USA